PAR 1 antagonist (Anchor Therapeutics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePAR 1 antagonist (Anchor Therapeutics)
Drug Alias Namepepducins (Ascent Therapeutics)protease-activated receptor 1 antagonists (Anchor Therapeutics)PAR 1 antagonist (Ascent Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProtease-activated receptor-1 antagonists
TargetsProtease-activated receptor-1
Therapy Area/IndicationsCardiovascular DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAnchor Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnchor Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCardiovascular DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A